Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors

被引:22
作者
Ferraccioli, G. [1 ]
Romano, G. [2 ]
机构
[1] Univ Cattolica Sacro Cuore, Sch Med, Div Rheumatol, CIC, I-00168 Rome, Italy
[2] Univ Udine, Nephrol Unit, I-33100 Udine, Italy
关键词
hepatocyte growth factor; interstitial damage; prognosis; systemic lupus erythematosus; transforming growth factor beta 1;
D O I
10.1177/0961203307088002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interstitial cells, inflammatory-immune cells, tubular cells and endothelial cells of the peritubular capillaries have arisen as possible major players of the nephron damage in lupus nephritis. Increased ICAM-1, Von Willebrand factor, soluble endothelial protein C receptors and decreased ADAMS-13 point to a diffuse vascular damage. Albuminuria elicits a rapid generation of hydrogen peroxide in proximal tubular cells along with nuclear factor-kB activation, endothelin-1 and transforming growth factor (TGF-beta 1) upregulation. TGF-beta 1 enhances epithelial-to-mesenchymal transdifferentiation. Albuminuria, also enhances the expression of macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha, thus leading to increased interstitial inflammation. TGF-beta 1 and thrombospondin-1, a putative activator of TGF-beta, induce apoptosis of peritubular capillaries, as well as of glomerular endothelial cells. All these events can be counteracted by hepatocyte growth factor (HGF), which is expressed by the epithelia] tubular cells and stimulates the growth of epithelia] cells (mitogen), enhances the motility of epithelial cells (motogen), induces renal epithelial tubule regeneration (morphogen) and enhances angiogenesis (angiogen). The balance between TGF-beta 1 and HGF could be a key to define the prognostic value of kidney histopathology at baseline and during follow-up, in lupus nephritis. Therapeutic strategies aiming at altering the biological balance in the patients are at hand to test and prove the experimental evidences.
引用
收藏
页码:533 / 540
页数:8
相关论文
共 62 条
[1]   PREDICTING RENAL OUTCOMES IN SEVERE LUPUS NEPHRITIS - CONTRIBUTIONS OF CLINICAL AND HISTOLOGIC DATA [J].
AUSTIN, HA ;
BOUMPAS, DT ;
VAUGHAN, EM ;
BALOW, JE .
KIDNEY INTERNATIONAL, 1994, 45 (02) :544-550
[2]   Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure [J].
Bao, Lihua ;
Wang, Ying ;
Chang, Anthony ;
Minto, Andrew W. ;
Zhou, Jian ;
Kang, Hong ;
Haas, Mark ;
Quigg, Richard J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (03) :811-822
[3]   Involvement of renal tubular toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus [J].
Benigni, Ariela ;
Caroli, Cristina ;
Longaretti, Lorena ;
Gagliardini, Elena ;
Zoja, Carla ;
Galbusera, Miriam ;
Moioli, Daniela ;
Romagnani, Paola ;
Tincani, Angela ;
Andreoli, Laura ;
Remuzzi, Giuseppe .
ARTHRITIS AND RHEUMATISM, 2007, 56 (05) :1569-1578
[4]  
Cameron JS, 1999, J AM SOC NEPHROL, V10, P413
[5]   Hepatocyte growth factor and transforming growth factor β1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis [J].
Capuano, Anna ;
Costanzi, Stefano ;
Peluso, Giusy ;
Zannoni, Gianfranco ;
Vellone, Valerio Gaetano ;
Gremese, Elisa ;
Zoli, Angelo ;
Scott, Cathryn ;
Beltrami, Carlo Alberto ;
Romano, Giulio ;
Ferraccioli, Gianfranco .
ARTHRITIS AND RHEUMATISM, 2006, 54 (11) :3633-3639
[6]   Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine [J].
Chan, TM ;
Tse, KC ;
Tang, CSO ;
Lai, K ;
Li, FK .
LUPUS, 2005, 14 (04) :265-272
[7]   PRESENCE OF COMPLEMENT-FIXING ANTI-ENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
CINES, DB ;
LYSS, AP ;
REEBER, M ;
BINA, M ;
DEHORATIUS, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :611-625
[8]   Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone [J].
Cortés-Hernández, J ;
Ordi-Ros, J ;
Labrador, M ;
Segarra, A ;
Tovar, JL ;
Balada, E ;
Vilardell-Tarres, M .
LUPUS, 2003, 12 (04) :287-296
[9]   Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice [J].
Dai, CS ;
Yang, JW ;
Bastacky, S ;
Xia, JL ;
Li, YJ ;
Liu, YH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (10) :2637-+
[10]  
DAMICO G, 1986, Q J MED, V59, P363